已发表论文

灵芝多糖和灵芝三萜在癌症放化疗中的多功能作用

 

Authors Xu J, Chen F, Wang G, Liu B, Song H, Ma T

Received 11 May 2021

Accepted for publication 27 July 2021

Published 17 August 2021 Volume 2021:13 Pages 6507—6516

DOI https://doi.org/10.2147/CMAR.S319732

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Chien-Feng Li

Abstract: G. lucidum has a long history of thousands of years in China and is closely related with the lives of the Chinese people. It is reported to cure various diseases due to its high nutritional value and wide range of uses. The fascinating effects of G. lucidum have tethered a multitude of efforts to explore its effective ingredients and supplement functions. At present, many cancer research studies have reported the G. lucidum polysaccharides (GLPs) and G. lucidum triterpenes (GLTs) as the main active ingredients in G. lucidum, which have shown positive effects on radiotherapy and chemotherapy. GLPs or GLTs treatment synergizes with radiotherapy and chemotherapy through multiple pathways, including oxidative stress, apoptosis, immune microenvironment, etc. Therefore, this review aims to analyze and summarize these complex molecules from G. lucidum in order to create more treatment options for cancer patients in the future.
Keywords: GLP, GLTs, pharmacology, general structure, radiotherapy and chemotherapy